Gilgamesh Pharmaceuticals
New accelerator entry · 2020-09-10 · the record
In their words
Gilgamesh is a pioneering, clinical stage mental health science-focused biotechnology company. We have a disciplined focus on developing innovative new chemical entities (NCEs) leveraging a unique combination of medicinal chemistry, intellectual property strategy, neuroscience & neurobiology, and drug development expertise. We are an experienced team, with proven success in biotech exits and inventions.
What the record says
- One of 59 companies held here in Healthcare › Drug Discovery and Delivery.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
The full profile
Source Check, INVEST, RECRUIT and Press Requests on Gilgamesh Pharmaceuticals
- Source Check — verify what Gilgamesh Pharmaceuticals states, against the registers that hold it.
- INVEST — size up this company on the figures its record states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with Gilgamesh Pharmaceuticals for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Gilgamesh PharmaceuticalsYou get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Gilgamesh Pharmaceuticals: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. FoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry.